Straumann recently formed a partnership with Anthogyr, enabling the company to invest in Anthogyr as well as address a broader section of the China dental implant market. Anthogyr’s dental implant system is registered and established in China.
Anthogyr’s implantology business activities in China are expected to be transferred to Straumann by mid-year, according to a press release, giving them access to this fast-growing value segment.
Straumann already leads the premium segment in China and recently established a new country organization and distributor network that covers all provinces.
Straumann also will acquire a 30 percent stake in Anthogyr and offers potential leverage to business in other markets through Instradent, a business platform Straumann is building to address the global value segment with multiple brands.
Financial details weren’t disclosed. The agreement is expected to become effective at the end of March.
View Full Press Release